Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Adverse Reactions to Aminopenicillins

Cutaneous Reactions

  • Aminopenicillins, such as amoxicillin, are associated with delayed-onset maculopapular exanthems in less than 7% of patients, often requiring concurrent viral infection, particularly Epstein-Barr virus 1
  • For pediatric patients with a history of benign cutaneous reactions, such as maculopapular exanthems or urticaria, the American Academy of Allergy, Asthma, and Immunology recommends direct amoxicillin challenge without prior skin testing 1

Recognition and Management of Serious Conditions

  • Early recognition and management of non-blanching rashes is critical, as conditions like meningococcal disease can progress rapidly with significant morbidity and mortality if not promptly treated 2
  • The distribution pattern of petechiae can be consistent with known causes, such as dependent areas or pressure points, according to the American Society of Hematology 3
  • Visual inspection by an experienced clinician is often sufficient for diagnosis, and overreliance on laboratory testing can be avoided, as recommended by clinical guidelines 3

Hematoma and Ecchymosis

  • A hematoma is a localized accumulation of blood in a space or cavity, forming a palpable mass, often fluctuant, and can affect deeper tissues, being intramural or forming a defined collection, according to the European Heart Journal 4
  • Hematomas can be detected using ultrasonography, computed tomography (CT), or magnetic resonance imaging (MRI), showing a defined collection, as reported by the Journal of the American College of Radiology 5
  • MRI with subtraction technique can help differentiate between simple hematomas and hemorrhagic tumors, as noted by the Journal of the American College of Radiology 5
  • Ecchymosis, a type of skin lesion (>10 mm, often several centimeters), commonly known as bruises, initially appears red/purple, then changes color over time (blue, green, yellow), and involves deeper layers of skin and subcutaneous tissue 6

Petechiae

  • Petechiae can be caused by various conditions, including bacterial infections (e.g., Meningococcemia), viral infections (e.g., Enteroviral infections, Epstein-Barr virus), and bleeding disorders, as reported by the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) 7, 6, 8
  • Rickettsial infections, such as Rocky Mountain Spotted Fever, are a cause of petechiae, according to the American Academy of Family Physicians 9
  • The differential diagnosis of petechiae includes:

    Condition Characteristics
    Ehrlichiosis Fever, headache, malaise, myalgia, rash, gastrointestinal manifestations
    Severe cutaneous adverse reactions Skin sloughing >30% body surface area, mucosal involvement, blistering, Stevens-Johnson syndrome, toxic epidermal necrolysis
    Juvenile Dermatomyositis (JDM) Characteristic rash, proximal muscle weakness
    Kawasaki disease Fever, rash, lymphadenopathy, desquamation
    Immune thrombocytopenia (ITP) Isolated thrombocytopenia, normal white blood cell and red blood cell counts
    Thrombotic thrombocytopenic purpura (TTP) Thrombocytopenia, microangiopathic hemolytic anemia, renal failure, neurological symptoms
    Hemophilia Bleeding into joints or muscles, prolonged bleeding after trauma or surgery
    Von Willebrand disease Easy bruising, nosebleeds, heavy menstrual bleeding

Evaluation and Management

  • The initial evaluation of a patient presenting with petechiae should include a complete medical history, physical examination, and laboratory tests, such as complete blood count (CBC) with peripheral smear, coagulation profile, renal function, liver function tests, and C-reactive protein (CRP) and/or erythrocyte sedimentation rate (ESR), as recommended by the Infectious Diseases Society of America 10, 11
  • Urgent evaluation is required if petechiae are accompanied by fever, rapidly progressing rash, rash covering >30% body surface area, or non-blanching petechial or purpuric rash, considering sepsis evaluation, as recommended by the American Academy of Pediatrics and the CDC 10, 12, 7, 6
  • Immediate empiric antibiotics should be administered if sepsis is suspected, without delaying treatment while awaiting laboratory confirmation, and considering doxycycline if tick-borne illness is possible, as recommended by the CDC 12
  • Platelet transfusion and hematology consultation should be considered in patients with platelets <20,000/μL and active bleeding, as recommended by the American Society of Hematology 13
  • Treatment decisions for ITP should be based on bleeding risk and platelet count, according to the American Society of Hematology 3
  • Hematomas may require drainage if they are large, symptomatic, or located in critical areas, according to Haematologica 14

REFERENCES

1

drug allergy: a 2022 practice parameter update. [LINK]

Journal of Allergy and Clinical Immunology, 2022

5

acr appropriateness criteria<sup>®</sup> soft-tissue masses. [LINK]

Journal of the American College of Radiology, 2018